Name: Latest research reports of Blue Jet Healthcare Ltd authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Blue Jet Healthcare Ltd
Rating: 5
Author: Motilal Oswal

Blue Jet Healthcare Ltd

NSE: BLUEJET | BSE: 544009 | ISIN: INE0KBH01020 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

837.6500 -5.90 (-0.70%)

NSE Jul 02, 2025 15:31 PM

109.41% Gain from 52W Low

Volume: 229.6K

Blue Jet Healthcare Ltd

14 May 2025

837.65

-0.70%

Encouraging 2HFY25; gears up for the next leg of growth

Buy: Blue Jet Healthcare Ltd

Motilal Oswal

Blue Jet Healthcare (BLUEJET)’s 4QFY25 revenue jumped 85% YoY to INR3.4b, primarily driven by higher sales in Pharma Intermediates (PI).

Number of FII/FPI investors increased from 37 to 72 in Mar 2025 qtr.